Panchsheel Organics Limited

BSE:531726 Stock Report

Market Cap: ₹2.4b

Panchsheel Organics Past Earnings Performance

Past criteria checks 1/6

Panchsheel Organics has been growing earnings at an average annual rate of 27%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 20.6% per year. Panchsheel Organics's return on equity is 10.9%, and it has net margins of 12.9%.

Key information

27.0%

Earnings growth rate

21.7%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate20.6%
Return on equity10.9%
Net Margin12.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Panchsheel Organics makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:531726 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,101142730
30 Jun 241,066141680
31 Mar 241,052141680
31 Dec 231,035143660
30 Sep 231,058140660
30 Jun 231,065140590
31 Mar 231,032141620
31 Dec 22966141590
30 Sep 22842112550
30 Jun 22749101540
31 Mar 2269084520
31 Dec 2158263510
30 Sep 2154657500
30 Jun 2155057470
31 Mar 2149650480
31 Dec 2049653490
30 Sep 2049752490
30 Jun 2047452460
31 Mar 2050553500
31 Dec 1948748490
30 Sep 1950749480
30 Jun 1949745460
31 Mar 1948540460
31 Dec 1849243440
30 Sep 1846038460
30 Jun 1844837450
31 Mar 1842437420
31 Dec 1738730440
30 Sep 1739331360
30 Jun 1740329340
31 Mar 1740132350
31 Dec 1642032300
30 Sep 1639630310
30 Jun 1640028290
31 Mar 1640430280
31 Dec 1538531390
30 Sep 1538629380
30 Jun 1537026750
31 Mar 1535819220
31 Dec 1439216360
30 Sep 1438212320
30 Jun 1438116320
31 Mar 1439218330

Quality Earnings: 531726 has a high level of non-cash earnings.

Growing Profit Margin: 531726's current net profit margins (12.9%) are lower than last year (13.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 531726's earnings have grown significantly by 27% per year over the past 5 years.

Accelerating Growth: 531726's earnings growth over the past year (1.9%) is below its 5-year average (27% per year).

Earnings vs Industry: 531726 earnings growth over the past year (1.9%) did not outperform the Pharmaceuticals industry 20.5%.

Return on Equity

High ROE: 531726's Return on Equity (10.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 06:10
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Panchsheel Organics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution